ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

4 links0 made here, not in the record6 judgments2 judges (our rules as one)0 record changes seen
Claude Opus 5.5Our rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07008976Clinical Trial of TQB2102for Injection VersusTrastuzumab Emtansine forInjection in HER2-positiveAdvanced Breast CancerChia Tai Tianqing PharmaceuticPhase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSBreast NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionDRUGSAnti-HER2/Topoisomerase I I…Entry “TQB2102 Injection”, read by ou…›Nov 18 · Our role rule · TestedTestedAdo-Trastuzumab EmtansineEntry “Trastuzumab Emtansine for Inje…›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Our role rule · ComparatorComparatorTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Not givenNot given

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Ado-Trastuzumab Emtansine

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Trastuzumab Emtansine for Injection”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Comparator
Comparator · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2Ado-Trastuzumab EmtansineClaude Opus 5.5ComparatorCurrent
Nov 2TrastuzumabClaude Opus 5.5Not givenCurrent
Nov 14Breast NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 18Anti-HER2/Topoisomerase I Inhibitor ADC TQB2102Our role ruleTestedCurrent
Nov 18Ado-Trastuzumab EmtansineOur role ruleComparatorAgrees
As of nowBreast NeoplasmsOur main-condition rule (R9)Main conditionCurrent